Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Lustgarten

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Cancer Immunology, Immunotherapy : CII|February 25, 2009
Cancer, aging and immunotherapy: lessons learned from animal modelsJoseph Lustgarten
Cancer Immunology, Immunotherapy : CII|June 27, 2003
Anti-Her-2/neu-IL-2 or heregulin-IL-2 fusions proteins redirect non-tumor specific CTL to the tumor site for tumor eradicationJoseph Lustgarten
Cancer Research|July 3, 2008
Implications of aging and self-tolerance on the generation of immune and antitumor immune responsesAna Lucia Dominguez, Joseph Lustgarten
Vaccine|November 26, 2009
Targeting the tumor microenvironment with anti-neu/anti-CD40 conjugated nanoparticles for the induction of antitumor immune responsesAna Lucia Dominguez, Joseph Lustgarten
European Journal of Immunology|March 3, 2004
The CD8+ T cell repertoire against Her-2/neu antigens in neu transgenic mice is of low avidity with antitumor activityJoseph Lustgarten, Ana Lucia Dominguez, Camilo Cuadros
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Identification of cross-reactive peptides using combinatorial libraries circumvents tolerance against Her-2/neu-immunodominant epitopeJoseph Lustgarten, Ana L Dominguez, Clemencia Pinilla
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2004
Aged mice develop protective antitumor immune responses with appropriate costimulationJoseph Lustgarten, Ana Lucia Dominguez, Marilyn Thoman
Experimental Gerontology|November 18, 2005
Aging affect the anti-tumor potential of dendritic cell vaccination, but it can be overcome by co-stimulation with anti-OX40 or anti-4-1BBSanjay Sharma, Ana Lucia Dominguez, Joseph Lustgarten
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
High accumulation of T regulatory cells prevents the activation of immune responses in aged animalsSanjay Sharma, Ana Lucia Dominguez, Joseph Lustgarten
Aging and Disease|March 8, 2012
Immunity, cancer and aging: lessons from mouse modelsCheryl E Myers, Noweeda N Mirza, Joseph Lustgarten
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Cancer Immunology, Immunotherapy : CII|February 25, 2009
Cancer, aging and immunotherapy: lessons learned from animal modelsJoseph Lustgarten
Cancer Immunology, Immunotherapy : CII|June 27, 2003
Anti-Her-2/neu-IL-2 or heregulin-IL-2 fusions proteins redirect non-tumor specific CTL to the tumor site for tumor eradicationJoseph Lustgarten
Cancer Research|July 3, 2008
Implications of aging and self-tolerance on the generation of immune and antitumor immune responsesAna Lucia Dominguez, Joseph Lustgarten
Vaccine|November 26, 2009
Targeting the tumor microenvironment with anti-neu/anti-CD40 conjugated nanoparticles for the induction of antitumor immune responsesAna Lucia Dominguez, Joseph Lustgarten
European Journal of Immunology|March 3, 2004
The CD8+ T cell repertoire against Her-2/neu antigens in neu transgenic mice is of low avidity with antitumor activityJoseph Lustgarten, Ana Lucia Dominguez, Camilo Cuadros
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Identification of cross-reactive peptides using combinatorial libraries circumvents tolerance against Her-2/neu-immunodominant epitopeJoseph Lustgarten, Ana L Dominguez, Clemencia Pinilla
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2004
Aged mice develop protective antitumor immune responses with appropriate costimulationJoseph Lustgarten, Ana Lucia Dominguez, Marilyn Thoman
Experimental Gerontology|November 18, 2005
Aging affect the anti-tumor potential of dendritic cell vaccination, but it can be overcome by co-stimulation with anti-OX40 or anti-4-1BBSanjay Sharma, Ana Lucia Dominguez, Joseph Lustgarten
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
High accumulation of T regulatory cells prevents the activation of immune responses in aged animalsSanjay Sharma, Ana Lucia Dominguez, Joseph Lustgarten
Aging and Disease|March 8, 2012
Immunity, cancer and aging: lessons from mouse modelsCheryl E Myers, Noweeda N Mirza, Joseph Lustgarten
Pageof 3